BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Timing is Everything: When is the Best Time to Ask for a Raise?

  One of the forgotten aspects of salary negotiations is “timing,” and being unaware of what to say. So, to decide what’s the best time to ask for a raise? The answer is here.

  September 6, 2018

   · 

  3 min read

   · 

  Editorial Staff
• 

  Business

  As Part of Global Restructuring, GlaxoSmithKline Pink-Slips 650 in the U.S.

  As part of an earlier announced restructuring program, UK-based GlaxoSmithKline is laying off 650 staffers in the U.S. GlaxoSmithKline employees approximately 15,000 people in the U.S.

  September 6, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Novartis Dumps 300 Sandoz Assets for $1 Billion to Aurobindo

  Today Narasimhan and Novartis announced they were selling U.S. dermatology and generic drug assets, parts of its Sandoz division, to India’s Aurobindo Pharma for up to $1 billion. The deal includes approximately 300 products.

  September 6, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Hospitals Launch Generic Drug Company Civica Rx to Drive Down Drug Prices

  In January, it was announced that five healthcare systems were launching a not-for-profit generic drug company. That company now has a name, Civica Rx.

  September 6, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Roche Veteran Sanjay Keswani Takes CEO Role at Startup Rheos Medicines

  Six months after launching with $60 million, Cambridge, Mass.-based Rheos Medicines has tapped Roche veteran Sanjay Keswani as the startup’s new chief executive officer.

  September 6, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  September 7 Research Roundup: Antibiotics, Human Genes, ALS, Sherpas and More

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

  September 6, 2018

   · 

  7 min read

   · 

  Mark Terry
• 

  Business

  With Phase II Win for Ankylosing Spondylitis, Gilead and Galapagos’ Filgotinib Inches Toward Approval

  Gilead Sciences and its partner Galapagos NV announced results from its Phase II TORTUGA clinical trial of filgotinib, a selective JAK1 inhibitor, in adults with moderately to severely active ankylosing spondylitis (AS).

  September 6, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  China’s Beigene Teams up With Springworks to Target Advanced Solid Tumors

  SpringWorks Therapeutics and BeiGene, Ltd. have teamed up to develop therapeutics that will target advanced solid tumors that contain RAS mutations, as well as other MAPK aberrations.

  September 6, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  CRISPR Pioneer Jennifer Doudna Opens Lab at Bay Area’s Gladstone Institutes

  CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.

  September 6, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  The Theranos Saga Ends, Company Closes Its Doors for Good

  Hours after it was reported that Elizabeth Holmes was shutting down Theranos for good, the company’s website has gone dark.

  September 6, 2018

   · 

  2 min read

   · 

  Alex Keown